GrantRover ↗

← Alle Förderungen

TÜBİTAK · Türkei

EP PerMed 2027 — Cell and Gene Therapies for Personalised Medicine (Turkey participation)

Offen

Die Einreichungsfrist endet am 20. Januar 2027.

Frist
20. Januar 2027 (in 66 Tagen)
Fördersumme
Nicht angegeben — siehe offizielle Ausschreibung
Förderquote
Siehe offizielle Ausschreibung
Fördergeber
TÜBİTAK
Referenz
EP-PERMED-CGT4PM2027-TR
Zuletzt geprüft
11. November 2026

Offizielle Ausschreibung öffnen ↗ Frist zum Kalender hinzufügen

Hinweis: international consortium and national application required.

Programmübersicht

The 2027 joint call supports development and validation of innovative cell and gene therapies for personalised human medicine. Approaches include somatic-cell therapies, gene therapies, combined cell/gene therapies and specified biological products. Proposals are submitted by multinational consortia through a two-stage international process.

Wer kann sich bewerben?

Participating Turkish researchers must also submit a national application to TÜBİTAK. The national route uses programme 1071; consortium and national eligibility rules both apply.

Antragstellerkategorien sind nur ein Ausgangspunkt. Über die Antragsberechtigung entscheidet die offizielle Ausschreibung.

Zeitplan

International short proposal: 20 January 2027, 14:00 CET. National submissions and later stages have separate deadlines; consult the official call timetable.

So bewerben Sie sich

  1. Check consortium composition, scientific scope and national eligibility.
  2. Coordinate the international short proposal before 20 January 2027, 14:00 CET.
  3. Complete the separate TÜBİTAK national application and any later stages on their own schedules.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
The national route uses programme 1071; consortium and national eligibility rules both apply.
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

Offizielle Quellen

Offizielle Ausschreibungsseite

Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 11. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.

Weitere Ausschreibungen: TÜBİTAK

TÜBİTAK Türkei

TÜBİTAK 1507 — SME R&D Start-up, 2026 second call

TUBITAK-1507-2026-2

The official 9 November extension notice sets the revised dates for the second 2026 SME R&D Start-up call. The programme supports SME R&D and innovation; the call documen…

TÜBİTAK Türkei

TÜBİTAK 1707 — Order-based SME R&D, 2026 third call

TUBITAK-1707-2026-3

Order-based SME R&D support under the third 2026 call. TÜBİTAK’s extension notice gives the revised pre-registration and closing dates; applicants must consult the linked…

TÜBİTAK Türkei

1831 Yeşil İnovasyon Teknoloji Mentörlük Çağrısı

TÜBİTAK 1831

1831 - Yeşil İnovasyon Teknoloji Mentörlük Çağrısı. Call listed on TÜBİTAK's official open-calls page.

TÜBİTAK Türkei Programm

TÜBİTAK 1001 — Scientific and Technological Research Projects

TUBITAK-1001

Supports scientifically based projects that generate knowledge, scientific interpretation or solutions to technological problems. Projects may last up to 36 months. This …

TÜBİTAK Türkei Programm

TÜBİTAK 1002-A — Rapid Support Module

TUBITAK-1002-A

Small, short research and doctoral-project R&D support at universities, research hospitals and research institutes. The official page states a maximum duration of 12 mont…